Company Profile

BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and veterinary drugs. Additionally, the Company offers its products to both domestic and overseas markets.

Employees

236

Sector

Pharmaceuticals

More about the company

27/21/27	Taisho Pharmaceutical Holdings Co., Ltd. completed the acquisition of remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers.	CI
14/21/14	Taisho Pharmaceutical Holdings Co., Ltd. executed a share exchange agreement to acquire remaining 37% stake in Biofermin Pharmaceutical Co., Ltd. from a group of sellers for ¥14.8 billion.	CI
18/17/18	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	CI
02/17/02	Taisho and Takeda Terminate Agreement on the Distribution of Biofermin Pharmaceutical's OTC Drugs and Quasi-Drugs	CI
19/16/19	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to S&P Global BMI Index	CI
21/15/21	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) dropped from S&P Global BMI Index	CI
31/13/31	Takeda Pharmaceutical Company Limited and Taisho Pharmaceutical Co., Ltd. Agrees Conduct Domestic Transactions in Relation to Sale of Products Manufactured by Biofermin Pharmaceutical	CI
31/13/31	Taisho Pharmaceutical Co., Ltd. entered into a share purchase arrangement to acquire an additional 8.14% stake in Biofermin Pharmaceutical Co., Ltd. from Takeda Pharmaceutical Company Limited.	CI
25/13/25	Biofermin Pharmaceutical Co., Ltd.(TSE:4517) added to Japan TOPIX Index	CI

Manager	Title	Age	Since
Toshimichi Kunori PSD	President	55	01/04/2021
Hidehiko Kitamura IRC	Investor Relations Contact	62	01/10/2019

Director	Title	Age	Since
Hideyuki Waki BRD	Director/Board Member	83	01/06/2008
Ken Uehara CHM	Chairman	48	01/06/2017
Toru Kawasaki BRD	Director/Board Member	76	24/06/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOFERMIN PHARMACEUTICAL CO., LTD.	-0.79%	+0.81%	-	-	34Cr
ELI LILLY AND COMPANY	+2.96%	+3.01%	+59.87%	+173.31%	1,10200Cr
JOHNSON & JOHNSON	+3.05%	+5.23%	+72.11%	+67.81%	64TCr
ABBVIE INC.	-0.04%	+1.20%	+35.72%	+87.93%	45TCr
ROCHE HOLDING AG	+0.98%	-2.07%	+27.62%	+22.57%	34TCr
NOVARTIS AG	-0.95%	-0.79%	+28.65%	+47.90%	29TCr
NOVO NORDISK A/S	-2.71%	+1.06%	-27.94%	-40.79%	22TCr
AMGEN INC.	+0.45%	+1.65%	+25.65%	+68.35%	20TCr
GILEAD SCIENCES, INC.	+5.21%	+7.93%	+21.99%	+83.23%	17TCr
PFIZER INC.	+1.48%	-0.04%	-4.64%	-32.25%	14TCr
Average	+0.23%	+2.00%	+26.56%	+53.12%	39.39TCr
Weighted average by Cap.	+0.27%	+1.86%	+41.73%	+87.36%

Biofermin Pharmaceutical Co., Ltd. Share Price

Stocks

4517

JP3799800002

Pharmaceuticals

Latest news : Biofermin Pharmaceutical Co., Ltd.

Quotes and Performance

Managers and Directors: Biofermin Pharmaceutical Co., Ltd.

Other Pharmaceuticals

Company Profile